Abstract
The clinical features of dermatomyositis (DM) have a close relationship with myositis-specific antibodies. Clinically amyopathic dermatomyositis (CADM) is a subgroup of DM, which manifests as characteristic skin symptoms compatible with DM, such as Gottron's sign and heliotrope rash with no or mild muscle symptoms. Sometimes, a life-threatening rapidly progressing interstitial lung disease can complicate CADM. In recent years, anti-CADM-140/MDA5 antibodies have been observed in serum obtained from patients with CADM. Thus, measurement of antiCADM-140/MDA5 antibodies is useful for the diagnosis and prediction of prognosis of patients with CADM. Rec.4/8/2013, Acc.5/10/2013, pp223-227
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
